Physician profile
Steve C Stringfellow
NPI 1699795161
$3,016.38
in general payments reported to CMS, 2019-2025
34 companies · $13.89 in 2025
The $13.89 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,484 · 2020: $418 · 2021: $536 · 2022: $366 · 2023: $32.20 · 2024: $167 · 2025: $13.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.28 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $491.32 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.76 | 2019-2022 | |
| Glaxosmithkline, LLC. | $234.60 | 2019-2023 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $211.33 | 2019-2022 | |
| Lilly USA, LLC | $211.04 | 2019-2020 | |
| Novo Nordisk INC | $210.87 | 2019-2022 | |
| Abbvie INC. | $143.75 | 2021-2022 | |
| Dexcom, INC. | $129.10 | 2024 | Dexcom G7 Gss (161) |
| Sanofi-Aventis U.S. LLC | $94.29 | 2019-2022 | |
| Daiichi Sankyo INC. | $88.62 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $85.95 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.99 | 2019 | |
| Astellas Pharma US INC | $65.83 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $54.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $53.55 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $52.66 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $42.36 | 2021 | |
| Mylan Specialty L.P. | $40.39 | 2019-2020 | |
| Philips North America LLC | $37.98 | 2024 | (6346) Intrasight Mobile |
| Allergan, INC. | $36.49 | 2020 | |
| Intuitive Surgical, INC. | $28.51 | 2019 | |
| Antares Pharma, INC. | $25.53 | 2022 | |
| Avanir Pharmaceuticals, INC. | $25.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.99 | 2019 | |
| Bausch Health US, LLC | $22.47 | 2019 | |
| Phadia US INC. | $19.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.92 | 2019 | |
| Merck Sharp & Dohme LLC | $15.83 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.19 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.51 | 2019 | |
| Horizon Therapeutics Plc | $13.49 | 2019 | |
| Currax Pharmaceuticals LLC | $12.47 | 2022 | |
| Hikma Pharmaceuticals USA | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Stringfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.